The reduction of TNF-α in group of with MS was lower than in group of without MS, but there existed no statistical significance (−36.87 ± 46.35 vs −20.01 ± 65.54) (P = .3743) (Fig. 2C). This evidence concerns the gene TNF and myeloid sarcoma.